share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

SEC announcement ·  Apr 4 04:55
Summary by Futu AI
On April 1, 2024, CVS Health EVP and Chief Technology Officer, Mandadi Tilak, was granted 16,339 shares of common stock (RSU) as part of a transaction with the company. The grant, which was completed on the same day, was issued at no cost to the recipient. Following this transaction, Tilak's direct holdings in CVS Health increased to a total of 82,904 shares of common stock. This event reflects the company's ongoing incentive plans for its executive leadership.
On April 1, 2024, CVS Health EVP and Chief Technology Officer, Mandadi Tilak, was granted 16,339 shares of common stock (RSU) as part of a transaction with the company. The grant, which was completed on the same day, was issued at no cost to the recipient. Following this transaction, Tilak's direct holdings in CVS Health increased to a total of 82,904 shares of common stock. This event reflects the company's ongoing incentive plans for its executive leadership.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.